news Archives - Page 70 of 100 - Journal for Clinical Studies

Current Edition

news

GamaMabs Pharma sees two peer-reviewed articles published in Oncotarget, detailing the anti-tumor activity of GM102/3C23K

GamaMabs Pharma, a biotechnology company developing optimized therapeutic antibodies targeting AMHR2 for the treatment of cancer, today announces that two peer-review...

6 December 2017 news antibodies | cancer

Continue Reading →

news

CluePoints Responds to Sponsor and CRO Demand with Two New Appointments

CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments t...

6 December 2017 news assesment | clinical trial

Continue Reading →

news

ADC Bio signs construction agreement with sector specialists WHP

ADC Biotechnology (ADC Bio) – a specialist ADC contract services company with proprietary conjugation technology designed to overcome process and aggregation challeng...

6 December 2017 news antibody drug conjugate | biotechnology

Continue Reading →

news

Xultophy® reported a better option than basal-bolus insulin therapy to manage type 2 diabetes by participants in the DUAL VII clinical trial

Once-daily Xultophy® (insulin degludec/liraglutide) was a better option to manage diabetes compared to multiple daily injections of insulin (basal-bolus regimen). Thi...

5 December 2017 news clinical trial | diabetes

Continue Reading →

news

Plasticell and Anthony Nolan to partner in clinical trials of ex vivo expanded cord blood stem cells

Plasticell, a developer of innovative stem cell technologies and cell therapies, today announced it will collaborate with Anthony Nolan, a leading research organisati...

5 December 2017 news clinical trial | hematopoietic

Continue Reading →

news

Bioclinica Appoints David Herron as Chief Executive Officer

Bioclinica®, a world-leading provider of specialty clinical trial services, has appointed David Herron as the company’s next Chief Executive Officer, effective Januar...

1 December 2017 news appointment | bioclinica

Continue Reading →

news

Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety & Efficacy in Clinical Trials

Bioclinica®, the world-leading provider of technology-enabled solutions for clinical research, today announces the launch of Bioclinica Clinical Adjudication, a trans...

30 November 2017 news clinical | e-health

Continue Reading →

news

UK trial assessing AZ’ AZD1775 in head and neck cancer

A clinical trial testing AstraZeneca’s experimental drug AZD1775, an inhibitor of the cell cycle regulating protein WEE1, in patients with head and neck cancer has no...

29 November 2017 news chemotherapy | head and neck cancer

Continue Reading →

news

AZ teams up with G1 on lung cancer combination therapy

AstraZeneca has signed a deal with US group G1 Therapeutics to test the potential of a new combination therapy for lung cancer. The parties have signed a clinical tri...

29 November 2017 news lung cancer | Phase Ib/II study

Continue Reading →

news

WIRB-Copernicus Group Partners with Veeva Systems Inc to improve the speed and accuracy of institutional review board (IRB) document transfer

WIRB-Copernicus Group® (WCG), the worlds leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that...

29 November 2017 news clinical | document

Continue Reading →